Post Reply
6541-6560 of 6990
Ok. No problem. Its a bit confusing. The rights appn forms also different. The one purchased from mkt cannot apply for excess rights whereas the other one for entitled rights there is indication you can. Will check with broker again. Monday closing liao. Thks again for ur times. Hv a great weekends.
edwinjup ( Date: 13-Sep-2014 14:25) Posted:
Bro..u may wan to double confirm with ur broker..this Is the method I always use and I used for my ocbc r but i find ocbc right issues document did not indicate this method right or wrong leh..thanks
Stocky901 ( Date: 13-Sep-2014 13:29) Posted:
|
|
|
Bro..u may wan to double confirm with ur broker..this Is the method I always use and I used for my ocbc r but i find ocbc right issues document did not indicate this method right or wrong leh..thanks
Stocky901 ( Date: 13-Sep-2014 13:29) Posted:
Great. Thank you bro.
edwinjup ( Date: 13-Sep-2014 13:27) Posted:
| Yes...can apply at one go.... |
|
|
|
Price should pick up and follow DBS' s lead.
Great. Thank you bro.
edwinjup ( Date: 13-Sep-2014 13:27) Posted:
Yes...can apply at one go.....
Stocky901 ( Date: 13-Sep-2014 13:17) Posted:
| Any rights expert can help? If I entitled x rights shares and I bought y rights shares from open mkt, can I use ATM to exercise x+y shares in one go, or I need to enter 2 times separatly? Thk you very much. |
|
|
|
Yes...can apply at one go.....
Stocky901 ( Date: 13-Sep-2014 13:17) Posted:
| Any rights expert can help? If I entitled x rights shares and I bought y rights shares from open mkt, can I use ATM to exercise x+y shares in one go, or I need to enter 2 times separatly? Thk you very much. |
|
Any rights expert can help? If I entitled x rights shares and I bought y rights shares from open mkt, can I use ATM to exercise x+y shares in one go, or I need to enter 2 times separatly? Thk you very much.
It may seem like advice on hindsight. But the best strategy would have been to sell the rights on 1 sep @ 2.26 and buy ocbc from open mkt at $9 or even $8 if STI correct.
This ocbc right issue make me very hand tight....lol
chinastar ( Date: 11-Sep-2014 10:50) Posted:
chinese new year in 2015:)
Stocky901 ( Date: 08-Sep-2014 11:00) Posted:
| DMG has TP of $ 10.55. Jun bo? |
|
|
|
chinese new year in 2015:)
Stocky901 ( Date: 08-Sep-2014 11:00) Posted:
| DMG has TP of $ 10.55. Jun bo? |
|
Nope pretty sure u cant otherwise it would be a logistics nightmare for the lead manager
redevils ( Date: 09-Sep-2014 22:18) Posted:
Sorry. New to rights
I just apply for my rights at atm today. 125 shares
Can i still apply for excess rights at the atm again?
Thanks
|
|
Think u need to.check.with the agent...i worry if u apply two times for the same batch..might.void ur 125 shares.....so pls check.with the placement mgr better....i know they dont allow.combine cashier order for same batch of rights.....
redevils ( Date: 09-Sep-2014 22:18) Posted:
Sorry. New to rights
I just apply for my rights at atm today. 125 shares
Can i still apply for excess rights at the atm again?
Thanks
|
|
Sorry. New to rights
I just apply for my rights at atm today. 125 shares
Can i still apply for excess rights at the atm again?
Thanks
you believe analyst? they just trying to scare the market la
edwinjup ( Date: 08-Sep-2014 09:02) Posted:
Like these..better sell.ur rights...lol
traders ( Date: 08-Sep-2014 09:00) Posted:
From Tree Original
Note - Price catalyst
- 12-month price target: S$8.20 based on a Price to Book methodology.
- Catalyst: potential further pressure on capital ratios and further dilution
OCBC is seeking to raise S$3.37 billion via a rights issue to existing shareholders after its acquisition of Wing Hang Bank (WHB). According to its announcement, OCBC will sell up to 440 million new shares at the ratio of one new share for every eight shares held, with an offer price of $7.65 each. This price translates into a 25% discount from the bank&rsquo s closing price of $10.20 last Friday.
Closing at $10.20 yesterday, OCBC ended the day unchanged and is currently trading 4.7% above its 50-day moving average of $9.74.
Macquarie Equities Research (MER) has issued a report on OCBC yesterday morning with a 12 month target price of $8.20. Here are some excerpts from the report.
- OCBC announced a rights issue on 18 August.
- The 2 key questions are:
- Will this close the full capital shortfall after the WHB deal on a Basel 3 fully loaded basis?
- Does this remove the risks of further earnings dilution?
- The answer to both questions is No in MER&rsquo s view.
Impact
- Size of the rights issue above expectations &hellip Gross proceeds of S$ 3.4bn from the rights issue are above market expectations of S$ 2-3bn.
- &hellip but still not enough in MER&rsquo s view. In the announcement, no pro-forma capital ratios were disclosed by OCBC. MER estimates the pro-forma CET1 ratio post WHB (fully loaded Basel 3) to increase from 8.3% to 10.1% (2014E). This is still a S$3.5bn pro-forma capital shortfall to 12% CET1 based on MER&rsquo s estimates. DBS and UOB are comfortably above 12% already.
Earnings and target price revision
- No change. MER&rsquo s current forecast and target price are before the rights issue.
Price catalyst
- 12-month price target: S$8.20 based on a Price to Book methodology.
- Catalyst: potential further pressure on capital ratios and further dilution
Action and recommendation
- MER maintains their Underperform recommendation on OCBC.
- The S$ 3.4bn rights issue addresses around half of the pro-forma capital shortfall in MER&rsquo s view. Little transparency and disclosure on pro-forma capital ratios after the WHB deal are another reason for MER to remain guarded.
Source: Macquarie Research
|
|
|
|
Don't worry , be happy. Enjoy the ride after right placement.
goondoo ( Date: 09-Sep-2014 11:46) Posted:
| For all ocbc optimists, pray hard that dbs reach $20 and uob reach $25 then maybe ocbc can hold at current $9.7 to $9.8 levels. |
|
For all ocbc optimists, pray hard that dbs reach $20 and uob reach $25 then maybe ocbc can hold at current $9.7 to $9.8 levels.
Last day to trade ocbc r.....
DMG has TP of $ 10.55. Jun bo?
And u r waiting to scoop it up, right? :)
edwinjup ( Date: 08-Sep-2014 09:02) Posted:
Like these..better sell.ur rights...lol
traders ( Date: 08-Sep-2014 09:00) Posted:
From Tree Original
Note - Price catalyst
- 12-month price target: S$8.20 based on a Price to Book methodology.
- Catalyst: potential further pressure on capital ratios and further dilution
OCBC is seeking to raise S$3.37 billion via a rights issue to existing shareholders after its acquisition of Wing Hang Bank (WHB). According to its announcement, OCBC will sell up to 440 million new shares at the ratio of one new share for every eight shares held, with an offer price of $7.65 each. This price translates into a 25% discount from the bank&rsquo s closing price of $10.20 last Friday.
Closing at $10.20 yesterday, OCBC ended the day unchanged and is currently trading 4.7% above its 50-day moving average of $9.74.
Macquarie Equities Research (MER) has issued a report on OCBC yesterday morning with a 12 month target price of $8.20. Here are some excerpts from the report.
- OCBC announced a rights issue on 18 August.
- The 2 key questions are:
- Will this close the full capital shortfall after the WHB deal on a Basel 3 fully loaded basis?
- Does this remove the risks of further earnings dilution?
- The answer to both questions is No in MER&rsquo s view.
Impact
- Size of the rights issue above expectations &hellip Gross proceeds of S$ 3.4bn from the rights issue are above market expectations of S$ 2-3bn.
- &hellip but still not enough in MER&rsquo s view. In the announcement, no pro-forma capital ratios were disclosed by OCBC. MER estimates the pro-forma CET1 ratio post WHB (fully loaded Basel 3) to increase from 8.3% to 10.1% (2014E). This is still a S$3.5bn pro-forma capital shortfall to 12% CET1 based on MER&rsquo s estimates. DBS and UOB are comfortably above 12% already.
Earnings and target price revision
- No change. MER&rsquo s current forecast and target price are before the rights issue.
Price catalyst
- 12-month price target: S$8.20 based on a Price to Book methodology.
- Catalyst: potential further pressure on capital ratios and further dilution
Action and recommendation
- MER maintains their Underperform recommendation on OCBC.
- The S$ 3.4bn rights issue addresses around half of the pro-forma capital shortfall in MER&rsquo s view. Little transparency and disclosure on pro-forma capital ratios after the WHB deal are another reason for MER to remain guarded.
Source: Macquarie Research
|
|
|
|
Like these..better sell.ur rights...lol
traders ( Date: 08-Sep-2014 09:00) Posted:
From Tree Original
Note - Price catalyst
- 12-month price target: S$8.20 based on a Price to Book methodology.
- Catalyst: potential further pressure on capital ratios and further dilution
OCBC is seeking to raise S$3.37 billion via a rights issue to existing shareholders after its acquisition of Wing Hang Bank (WHB). According to its announcement, OCBC will sell up to 440 million new shares at the ratio of one new share for every eight shares held, with an offer price of $7.65 each. This price translates into a 25% discount from the bank&rsquo s closing price of $10.20 last Friday.
Closing at $10.20 yesterday, OCBC ended the day unchanged and is currently trading 4.7% above its 50-day moving average of $9.74.
Macquarie Equities Research (MER) has issued a report on OCBC yesterday morning with a 12 month target price of $8.20. Here are some excerpts from the report.
- OCBC announced a rights issue on 18 August.
- The 2 key questions are:
- Will this close the full capital shortfall after the WHB deal on a Basel 3 fully loaded basis?
- Does this remove the risks of further earnings dilution?
- The answer to both questions is No in MER&rsquo s view.
Impact
- Size of the rights issue above expectations &hellip Gross proceeds of S$ 3.4bn from the rights issue are above market expectations of S$ 2-3bn.
- &hellip but still not enough in MER&rsquo s view. In the announcement, no pro-forma capital ratios were disclosed by OCBC. MER estimates the pro-forma CET1 ratio post WHB (fully loaded Basel 3) to increase from 8.3% to 10.1% (2014E). This is still a S$3.5bn pro-forma capital shortfall to 12% CET1 based on MER&rsquo s estimates. DBS and UOB are comfortably above 12% already.
Earnings and target price revision
- No change. MER&rsquo s current forecast and target price are before the rights issue.
Price catalyst
- 12-month price target: S$8.20 based on a Price to Book methodology.
- Catalyst: potential further pressure on capital ratios and further dilution
Action and recommendation
- MER maintains their Underperform recommendation on OCBC.
- The S$ 3.4bn rights issue addresses around half of the pro-forma capital shortfall in MER&rsquo s view. Little transparency and disclosure on pro-forma capital ratios after the WHB deal are another reason for MER to remain guarded.
Source: Macquarie Research
|
|
From Tree Original
Note - Price catalyst
- 12-month price target: S$8.20 based on a Price to Book methodology.
- Catalyst: potential further pressure on capital ratios and further dilution
OCBC is seeking to raise S$3.37 billion via a rights issue to existing shareholders after its acquisition of Wing Hang Bank (WHB). According to its announcement, OCBC will sell up to 440 million new shares at the ratio of one new share for every eight shares held, with an offer price of $7.65 each. This price translates into a 25% discount from the bank&rsquo s closing price of $10.20 last Friday.
Closing at $10.20 yesterday, OCBC ended the day unchanged and is currently trading 4.7% above its 50-day moving average of $9.74.
Macquarie Equities Research (MER) has issued a report on OCBC yesterday morning with a 12 month target price of $8.20. Here are some excerpts from the report.
- OCBC announced a rights issue on 18 August.
- The 2 key questions are:
- Will this close the full capital shortfall after the WHB deal on a Basel 3 fully loaded basis?
- Does this remove the risks of further earnings dilution?
- The answer to both questions is No in MER&rsquo s view.
Impact
- Size of the rights issue above expectations &hellip Gross proceeds of S$ 3.4bn from the rights issue are above market expectations of S$ 2-3bn.
- &hellip but still not enough in MER&rsquo s view. In the announcement, no pro-forma capital ratios were disclosed by OCBC. MER estimates the pro-forma CET1 ratio post WHB (fully loaded Basel 3) to increase from 8.3% to 10.1% (2014E). This is still a S$3.5bn pro-forma capital shortfall to 12% CET1 based on MER&rsquo s estimates. DBS and UOB are comfortably above 12% already.
Earnings and target price revision
- No change. MER&rsquo s current forecast and target price are before the rights issue.
Price catalyst
- 12-month price target: S$8.20 based on a Price to Book methodology.
- Catalyst: potential further pressure on capital ratios and further dilution
Action and recommendation
- MER maintains their Underperform recommendation on OCBC.
- The S$ 3.4bn rights issue addresses around half of the pro-forma capital shortfall in MER&rsquo s view. Little transparency and disclosure on pro-forma capital ratios after the WHB deal are another reason for MER to remain guarded.
Source: Macquarie Research
